[Current problems in the treatment of human brucellosis].
D002002:Brucella / Q000302:isolation & purification; D002006:Brucellosis / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D002751:Chlortetracycline / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use
D013449:Sulfonamides; D014295:Trimethoprim; D013420:Sulfamethoxazole; D012293:Rifampin; D002751:Chlortetracycline; D013307:Streptomycin
Problemi attuali in tema di trattamento della brucellosi umana